Publications of F. Hausch
All genres
Journal Article (59)
41.
Journal Article
21 (Suppl. 3), pp. S189 - S190 (2011)
The involvement of FK506-binding protein 51 (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress. European Neuropsychopharmacology 42.
Journal Article
44 (6), p. 294 - 294 (2011)
The involvement of FKBP51 and FKBP52 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry 43.
Journal Article
44 (6), p. 294 - 294 (2011)
FBKP51 as a paradigm for translation and academic drug discovery. Pharmacopsychiatry 44.
Journal Article
133 (23), pp. 8927 - 8933 (2011)
Biomimetic Screening of Class-B G Protein-Coupled Receptors. Journal of the American Chemical Society 45.
Journal Article
67, pp. 549 - 559 (2011)
Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90. Acta Crystallographica Section D-Biological Crystallography 46.
Journal Article
20 (4), pp. 519 - 535 (2011)
Corticotropin releasing factor receptor antagonists for major depressive disorder. Expert Opinion on Investigational Drugs 47.
Journal Article
21 (Suppl. 1), pp. S8 - S9 (2011)
The involvement of FK506-binding protein 51 gene (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress. European Neuropsychopharmacology 48.
Journal Article
1 (9), pp. 536 - 539 (2010)
Facile Synthesis of a Fluorescent Cyclosporin A Analogue To Study Cyclophilin 40 and Cyclophilin 18 Ligands. ACS Medicinal Chemistry Letters 49.
Journal Article
42 (5), p. 215 - 215 (2009)
Biomimetic screening of CRHR ligands. Pharmacopsychiatry 50.
Journal Article
42 (5), p. 221 - 221 (2009)
The involvement of FKBP5 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry 51.
Journal Article
42 (5), p. 226 - 226 (2009)
Modified antidepressants as innovative tools for identifying novel drug targets. Pharmacopsychiatry 52.
Journal Article
42 (5), p. 227 - 227 (2009)
Steroid receptor folding and signaling is regulated by the Hsp70 cochaperones BAG-1 M and HspBP1. Pharmacopsychiatry 53.
Journal Article
42 (5), pp. 227 - 228 (2009)
Development of specific inhibitors for the FK506 binding proteins 51 and 52. Pharmacopsychiatry 54.
Journal Article
42 (5), p. 240 - 240 (2009)
Deletion of FKBP5 alters stress-related parameters in mice. Pharmacopsychiatry 55.
Journal Article
10 (8), pp. 1402 - 1410 (2009)
Fluorescent Probes to Characterise FK506-Binding Proteins. ChemBioChem 56.
Journal Article
583 (9), pp. 1493 - 1498 (2009)
XAP2 inhibits glucocorticoid receptor activity in mammalian cells. FEBS Letters 57.
Journal Article
9 (18), pp. 3083 - 3086 (2008)
EMBL Conference on Chemical Biology 2008. ChemBioChem 58.
Journal Article
47 (18), pp. 3314 - 3316 (2008)
Betablockers at work: The crystal structure of the β2-adrenergic receptor. Angewandte Chemie-International Edition 59.
Journal Article
40 (5), p. 210 - 210 (2007)
Proteomic search for intrcellular binding sites of antidepressants. Pharmacopsychiatry Book Chapter (1)
60.
Book Chapter
FKBP51 - ein neues Zielprotein zur Behandlung von Depression. Forschungsbericht 2009 - Max-Planck-Institut für Psychiatrie. In: Jahrbuch (Ed. Max-Planck-Gesellschaft). Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., München (2009)